ZULIAN, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.613
AS - Asia 1.032
EU - Europa 806
SA - Sud America 7
AF - Africa 6
OC - Oceania 2
Totale 8.466
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.606
SG - Singapore 464
CN - Cina 413
IT - Italia 187
DE - Germania 181
FI - Finlandia 155
RU - Federazione Russa 78
VN - Vietnam 66
HK - Hong Kong 59
GB - Regno Unito 52
FR - Francia 47
SE - Svezia 38
UA - Ucraina 36
IN - India 23
IE - Irlanda 12
AT - Austria 7
BR - Brasile 7
CA - Canada 6
NL - Olanda 5
EG - Egitto 4
CH - Svizzera 2
NZ - Nuova Zelanda 2
RO - Romania 2
BD - Bangladesh 1
BE - Belgio 1
DK - Danimarca 1
DZ - Algeria 1
GR - Grecia 1
ID - Indonesia 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
MX - Messico 1
PH - Filippine 1
SI - Slovenia 1
TN - Tunisia 1
TR - Turchia 1
Totale 8.466
Salva come PNG Salva come JPEG
Città #
Fairfield 1.287
Woodbridge 597
Houston 556
Ashburn 513
Cambridge 438
Seattle 426
Wilmington 389
Singapore 286
Chandler 284
Ann Arbor 282
Santa Clara 183
Boardman 173
Jacksonville 161
Princeton 158
San Diego 138
Medford 122
Helsinki 119
Beijing 117
Des Moines 89
Munich 79
Dong Ket 66
Hong Kong 59
Roxbury 49
Nanjing 46
Padova 38
Jinan 24
London 24
Hebei 21
Nanchang 19
Norwalk 14
Guangzhou 13
Shenyang 13
Dublin 12
Ningbo 12
Changsha 11
Nuremberg 11
Bologna 8
Zhengzhou 8
Borås 7
Kharkiv 7
Ogden 7
Tianjin 7
Falkenstein 6
Pune 6
Haikou 5
Jiaxing 5
Jyväskylä 5
Kilburn 5
Lanzhou 5
Fuzhou 4
Naples 4
New York 4
Rome 4
Shanghai 4
Taiyuan 4
Vienna 4
Coimbatore 3
Frankfurt am Main 3
Grado 3
Las Vegas 3
McKinney 3
Albignasego 2
Amsterdam 2
Bari 2
Cairo 2
Cape Coral 2
Caprino Veronese 2
Cebazat 2
Council Bluffs 2
Cupra Marittima 2
Ferrara 2
Hangzhou 2
Hounslow 2
Lappeenranta 2
Milan 2
Moscow 2
New Delhi 2
Noale 2
Nürnberg 2
Ottawa 2
Paris 2
Prescot 2
Qina 2
San Francisco 2
Southwark 2
Stockholm 2
Udine 2
Washington 2
Yellow Springs 2
Adana 1
Almaty 1
Auckland 1
Bagno A Ripoli 1
Banbalah 1
Barga 1
Bassano del Grappa 1
Bengaluru 1
Berlin 1
Brendola 1
Brescia 1
Totale 7.020
Salva come PNG Salva come JPEG
Nome #
Case report: Exploring under the tip of the iceberg: A case series of "self-limiting" multisystem inflammatory syndrome in children 165
A new computerized method for the assessment of skin lesions in Localized Scleroderma 161
Consensus-based recommendations for the management of juvenile localised scleroderma 136
Anti-DFS70 antibodies in healthy schoolchildren: A follow-up analysis 123
Synovial hemangioma of infrapatellar (Hoffa) fat pad: Magnetic resonance imaging and ultrasound features 120
Severe clinical course of systemic lupus erythematosus in the first year of life 108
Life-threatening systemic capillary leak syndrome in juvenile dermatomyositis 108
CXCR6-CXCL16 interaction in the pathogenesis of Juvenile Idiopathic Arthritis. 104
Congenital localized scleroderma 104
A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea) 100
Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis 100
CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis 98
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study 96
Musculoskeletal pain in schoolchildren across puberty: A 3-year follow-up study 95
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative 95
Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: Results from a phase 3, randomised, double-blind withdrawal trial 94
Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: A randomised trial 93
Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review 93
Update of EULAR recommendations for the treatment of systemic sclerosis 92
THU0532 RITUXIMAB FOR RAPIDLY PROGRESSIVE JUVENILE SYSTEMIC SCLEROSIS 92
A computerized method to assess the skin involvement in localized scleroderma. 91
Localized scleroderma of the face 89
Electrocardiographic abnormalities in infants born from mothers with autoimmune diseases - a multicentre prospective study 88
Photopheresis in paediatric patients with drug-resistant chronic graft-versus-host disease. 86
Abatacept for severe anti-tumor necrosis factor α refractory juvenile idiopathic arthritis-related uveitis 86
Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebo-controlled trial. 85
The European network for care of children with paediatric rheumatic diseases: care across borders 84
Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial 81
The pediatric rheumatology European Society American College of Rheumatology European league against rheumatism provisional classification criteria for juvenile systemic sclerosis 79
Sarcopenia in juvenile localized scleroderma: new insights on deep involvement 79
Distinctive clinical features of pediatric systemic lupus erythematosus in three different age classes 78
Recent advances in the management of juvenile systemic sclerosis 78
CXCL10/CXCR3 interaction mediate chemotaxis of T cell into the synovium of children with oligoarticular juvenile idiopathic arthritis. 78
Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy. 76
Long-term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patients 76
Clinical features and outcome of cogan syndrome 75
Reliability of LoSCAT score for activity and tissue damage assessment in a large cohort of patients with Juvenile Localized Scleroderma 75
Prevalence of antinuclear antibodies in schoolchildren during puberty and possible relationship with musculoskeletal pain: A longitudinal study 74
A preliminary disease severity score for juvenile systemic sclerosis 73
Early predictors at severe course of uveitis in oligoarticular Juvenile idiopathic arthritis 72
Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis 72
Consensus-based recommendations for the management of juvenile systemic sclerosis 72
Successful treatment of gangrene in systemic necrotizing vasculitis with iloprost 71
Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry 71
Bone involvement as presenting sign of pediatric-onset Gaucher disease 70
Comparable efficacy of abatacept used as first-line or second-line biological agent for severe juvenile idiopathic arthritis-related uveitis 69
Subset-specific effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro 69
Acquired strabismus in linear scleroderma of the face 69
The 1982 ARA/ACR criteria for theclassification of systemic lupus erythematosus in pediatric and adult patients 68
Monoarticular juvenile chronic arthritis of the shoulder: Report of a case and review of the literature 68
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children 68
CXCL10/CXCR3 interaction mediate chemotaxis of T cell into the synovium of children with oligoarticular juvenile idiopathic arthritis. 67
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients 67
Case of the month: A five-year-old girl with intractable arthralgias 64
Immunopathogenesis of pediatric localized scleroderma 64
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis 64
Otolaryngological manifestations of rheumatic diseases in children. 63
Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate 62
Immunopathogenesis of juvenile systemic sclerosis 62
Comparison of intra-articular triamcinolone hexacetonide and triamcinolone acetonide in oligoarticular juvenile idiopathic arthritis 61
Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA) 61
Case Report: Life-Threatening Macrophage Activation Syndrome With Fulminant Myocarditis Successfully Rescued by High Dose Intravenous Anakinra 60
Prolactin receptor levels on lymphocytes vary with menstrual cycle in women 59
Psychological profile in children and adolescents with severe course Juvenile idiopathic arthritis 59
Clinical impact of MEFV mutations in children with periodic fever in a prevalent western European Caucasian population 59
Infrared thermography in children: A reliable tool for differential diagnosis of peripheral microvascular dysfunction and Raynaud's phenomenon? 59
Joint hypermobility and oligoarticular juvenile idiopathic arthritis: What relationship? 58
Natural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review 58
Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma 58
Systemic Sclerosis and Localized Scleroderma in Childhood 58
Is there a role for arthroscopic synovectomy in oligoarticular juvenile idiopathic arthritis? 57
La porpora di Schonlein-Henoch 57
Cone beam computed tomography for the assessment of linear scleroderma of the face 57
Systemic sclerosis in childhood: Clinical and immunologic features of 153 patients in an international database 57
Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra 56
Reflex sympathetic dystrophy in children 56
A child with dermatomyositis and a suspicious lymphadenopathy. 55
Methotrexate in Linear Scleroderma: long-term efficacy in 50 children from a single Pediatric Rheumatology Centre 55
Juvenile idiopathic arthritis: Current and future treatment options 54
Disease-free interval as predictor of relapsy in early onset pauciarticular juvenile chronic arthritis 53
Methotrexate: New uses for an old drug 53
Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: Data from the Eustar database 52
Outcome measures and medical progress: why outcome measures are needed in childhood arthritis 51
Disease status, reasons for discontinuation and adverse events in 1038 Italian children with juvenile idiopathic arthritis treated with etanercept 51
Temporomandibular Joint Involvement in Association With Quality of Life, Disability, and High Disease Activity in Juvenile Idiopathic Arthritis 51
Treatment in Juvenile Scleroderma 51
Growth during tocilizumab therapy for polyarticular-course juvenile idiopathic arthritis: 2-year data from a phase III clinical trial 50
Is Intraarticular Corticosteroid Injection (IAC) an effective therapy for Temporomandibular Joint (TMJ) Involvement in JIA? 49
New developments in localized scleroderma 49
Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration 49
Osteoperiostitis in children: proposal for a diagnostic algorithm 49
Scleroderma in children: An update 48
Disease-free interval as predictor of relapsy of uveitis in early onset pauciarticular juvenile chronic arthritis 48
Methotrexate in juvenile idiopathic arthritis: Advice and recommendations from the MARAJIA expert consensus meeting 48
The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age 48
Rituximab for rapidly progressive juvenile systemic sclerosis 48
Concomitant severe Kawasaki disease and pityriasis rubra pilaris in a teenager: just a coincidence? 47
Early echocardiographic and cardiac mri findings in multisystem inflammatory syndrome in children 47
Long-Term Methotrexate Efficacy in Juvenile Localized Scleroderma 46
Localized scleroderma 46
Totale 7.248
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.168
article - articoli 36.041
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 266
Totale 74.475
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.159 0 0 0 0 0 0 0 0 469 340 192 158
2020/20211.729 119 218 115 137 157 51 29 183 252 130 225 113
2021/20221.638 56 192 176 129 90 60 83 166 191 36 122 337
2022/2023800 231 44 22 50 122 110 9 52 96 14 41 9
2023/2024567 21 75 69 36 57 33 52 24 27 9 76 88
2024/20251.440 25 189 82 90 435 129 180 240 70 0 0 0
Totale 8.672